NDC 73683-101

HYFTOR

Sirolimus

HYFTOR is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Nobelpharma America, Llc. The primary component is Sirolimus.

Product ID73683-101_dbdaca4e-b55c-7d41-e053-2995a90abb9a
NDC73683-101
Product TypeHuman Prescription Drug
Proprietary NameHYFTOR
Generic NameSirolimus
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2022-03-23
Marketing CategoryNDA /
Application NumberNDA213478
Labeler NameNobelpharma America, LLC
Substance NameSIROLIMUS
Active Ingredient Strength2 mg/g
Pharm ClassesDecreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 73683-101-10

1 TUBE in 1 CARTON (73683-101-10) > 10 g in 1 TUBE
Marketing Start Date2022-03-23
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "HYFTOR" or generic name "Sirolimus"

NDCBrand NameGeneric Name
0008-1030RapamuneSIROLIMUS
0008-1040RapamuneSIROLIMUS
0008-1041RapamuneSIROLIMUS
0008-1042RapamuneSIROLIMUS
0904-7147sirolimussirolimus
0904-7248SirolimusSirolimus
13668-658SirolimusSirolimus
16714-187sirolimussirolimus
16714-188sirolimussirolimus
16714-189sirolimussirolimus

Trademark Results [HYFTOR]

Mark Image

Registration | Serial
Company
Trademark
Application Date
HYFTOR
HYFTOR
88600269 not registered Live/Pending
Nobelpharma Co., Ltd.
2019-08-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.